Navigation Links
Genetic blueprint of bread wheat genome unveiled
Date:7/17/2014

This news release is available in French, Japanese, and German.

The genetic blueprint is an invaluable resource to plant science researchers and breeders. For the first time, they have at their disposal a set of tools enabling them to rapidly locate specific genes on individual wheat chromosomes throughout the genome. Jorge Dubcovsky, Professor at the University of California Davis, USA, says that these results "have been a fantastic resource for our laboratory. The development of genome specific primers, which used to take several weeks of work, can now be done in hours. Mapping of any sequence to the specific chromosome arm can now be done in silico in minutes. In addition to the acceleration of day to day work in wheat genetics, this resource has made possible analyses and discoveries at the genome level that were not possible before."

The draft sequence is a major landmark towards obtaining a complete reference sequence of the hexaploid bread wheat genome, the ultimate aim of the International Wheat Genome Sequencing Consortium. In the same issue of Science, another article presents the first reference sequence for the largest chromosome, 3B. This establishes a proof of concept and a template for sequencing the remaining chromosomes. As of today, researchers in the IWGSC estimate that the full genome sequence will be available within three years.

"With the draft gene sequence for each of the bread wheat chromosome and the first reference sequence of chromosome 3B, we have reached a great milestone in our roadmap," said Catherine Feuillet, IWGSC co-chair. "We know now the way forward to obtain a reference sequence for the 20 remaining chromosomes and we hopefully will be able to find the resources to achieve this in the next three years."

With a chromosome-based full sequence in hand, plant breeders will have high quality tools at their disposal to accelerate breeding programs and to identify how genes control complex traits such as yield, grain quality, disease, pest resistance, or abiotic stress tolerance. They will be able to produce a new generation of wheat varieties with higher yields and improved sustainability to meet the demands of a growing world population in a changing environment.

The draft sequence is already providing new insights into the history and evolution of the wheat genome and genes involved in grain development, as exemplified in two additional publications appearing in the same issue of Science.

Wheat is a major dietary component for many populations across the world. Grown on more land than any other crop, more than 215 million hectares of wheat are harvested annually to generate a world production of almost 700 million tons, making it the third most produced cereal after maize and rice. It is the leading source of vegetable protein in human food, having a higher protein content than either maize or rice. The wheat plant is highly versatile due to its ability to grow in a wide range of environments. Wheat grain is easily stored and can be converted readily into flour for making numerous varieties of high quality edible food.


'/>"/>

Contact: Isabelle Caugant
communications@wheatgenome.org
32-048-475-0634
International Wheat Genome Sequencing Consortium
Source:Eurekalert  

Related biology news :

1. First comprehensive library of master genetic switches in plants
2. Millennium Laboratories Expands Pharmacogenetic Test to Help Clinicians Prescribe the Right Medicine at the Right Dose
3. Wisconsin scientists find genetic recipe to turn stem cells to blood
4. New optogenetic tool for controlling neuronal signalling by blue light
5. CWRU and collaborators receive $12.6 million NIH grant to study genetics of Alzheimers
6. Researchers receive $12.6 million NIH grant to study genetics of Alzheimers
7. UCLA awarded $7 million to unravel mystery genetic diseases
8. Studies provide important new information on genetic risk of sudden cardiac death
9. Computer-aided diagnosis of rare genetic disorders from family snaps
10. Researchers develop genetic control mechanism for major livestock pest
11. Eight undergraduate students receive travel awards from the Genetics Society of America
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic blueprint of bread wheat genome unveiled
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
(Date:1/19/2017)... Oregon and PUNE, India , January 19, 2017 ... Research, titled, "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," ... growing at a CAGR of 9.6% from 2016 to 2022. In 2015, ... owing to high-level security for both public and private sectors. ... ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... According to a new ... Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, ... Development, Disease-Risk) - Global Forecast to 2021" published ... USD 53.34 Billion by 2021 from USD 27.95 ... 13.8% during the forecast period (2016-2021). ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor Therapeutics, ... clinical-stage biotechnology company developing first-in-class biological therapies for ... it has elected to terminate its license agreement ... receptor agonists, including Cenderitide. "Our decision ... as we prioritize our efforts to advance our ...
Breaking Biology Technology: